Similar Articles
991 Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: A pilot study
992 Two novel germline mutations of MLH1 and investigation of their pathobiology in hereditary non-polyposis colorectal cancer families in China
993 Moving forward in colorectal cancer research, what proteomics has to tell
994 Is there a genetic signature for liver metastasis in colorectal cancer?
995 Combining chemotherapy and targeted therapies in metastatic colorectal cancer
996 Pharmacogenomics in colorectal cancer: The first step for individualized-therapy
997 Novel translational strategies in colorectal cancer research
998 CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking
999 Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer
1000 Three novel missense germline mutations in different exons of MSH6 gene in Chinese hereditary non-polyposis colorectal cancer families
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA